High Prevalence of <i>Helicobacter pylori</i> Infection in Greek Patients with Myelodysplastic Syndromes

Male 0303 health sciences Greece Helicobacter pylori Middle Aged Helicobacter Infections 3. Good health Causality Cohort Studies Leukemia, Myeloid, Acute 03 medical and health sciences Antigens, CD Case-Control Studies Myelodysplastic Syndromes Humans Female Lymphocytes Aged
DOI: 10.1159/000319629 Publication Date: 2010-10-11T07:06:34Z
ABSTRACT
<i>Background/Aims/Methods:</i> To determine the frequency of <i>Helicobacter pylori</i> infection (<i>Hp</i>-I) in 73 patients with myelodysplastic syndromes (MDS) and 40 controls, serologic analyses of <i>Hp</i> and <sup>13</sup>C-urease breath tests (INFAI) were performed. Gastric mucosal biopsy specimens were obtained to determine the presence of <i>Hp</i>-I using a rapid urease test, i.e. the Campylobacter-like organism (CLO) test, and cresyl violet staining. Peripheral blood (PB) flow cytometry for CD3, CD4, CD8, CD14, CD19 and CD34 was conducted in 35 patients and in controls. <i>Results:</i><i>Hp</i>-I was detected by: (a) serology in 75.34% of patients (p = 0.000), (b) INFAI in 57.69% of patients, (c) CLO in 60.71% of patients and (d) histological confirmation in 80.36% of patients (p = 0.001). No correlation between <i>Hp</i>-I and CD3, CD4, CD8, CD14, CD19 expression, leukemic transformation or death was observed. However, in 20 cases, significant variation in the PB lymphocytic proportion possibly attributable to<i> Hp</i>-I was ascertained, in contrast to the expected MDS ratio. <i>Conclusion:</i> Although there is no evidence for a causal relationship between <i>Hp</i>-I and MDS, the increased prevalence of <i>Hp</i>-I among the MDS patients is an interesting finding that deserves further investigation as it may indicate a common factor causing susceptibilities to both MDS and <i>Hp</i>-I or that <i>Hp</i> might influence the pathophysiology of MDS.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....